Amesite shares jump 28.63% premarket after launching AI-native NurseMagic EMR, driving revenue growth and market expansion.

Amesite Inc. surged 28.63% in premarket trading following the announcement of its NurseMagic™ EMR launch, expanding its AI-driven platform into core post-acute care infrastructure. The modular EMR, which supports coexistence with legacy systems or full replacement, is positioned to capitalize on the $850 billion projected U.S. post-acute care market. The company highlighted prior revenue growth of 2.4x after the May 2025 Teams+ launch and an 82% increase post-Enterprise tier introduction in July 2025, underscoring its scalable product strategy. CEO Ann Marie Sastry emphasized the EMR’s alignment with patient-volume pricing and infrastructure-level solutions, while VP of Sales Brandon Owens noted competitive advantages in flexibility. The news reinforced investor confidence in Amesite’s market expansion and AI-native innovation, aligning with the surge in premarket activity.